Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.34 -0.01 (-0.43%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kiora Pharmaceuticals (KPRX) Long-Term Debt Issuances (2014)

Updated

Kiora Pharmaceuticals' Long-Term Debt Issuances came in at $278,190 for FY2020.

Analysis

Kiora Pharmaceuticals (KPRX) Long-Term Debt Issuances (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn -
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn -
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn -
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -
10 Kiora Pharmaceuticals 14.52 Mn -52.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 284,393.00
Sep 30, 2014 538,545.00
Jun 30, 2014 486,678.00
Mar 31, 2014 446,151.00
API Access

Kiora Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=KPRX&period=max&api_key=YOUR_API_KEY